2-es típusú diabetes mellitus, inzulinrezisztencia és májrák idült hepatitis C-fertozésben: Északkelet-magyarországi adatok

Translated title of the contribution: Type 2 diabetes mellitus, insulin resistance and hepatocellular carcinoma in chronic hepatitis C patients: Data from Northeastern Hungary

Lombay Béla, Szilágyi Roland, F. Szalay

Research output: Contribution to journalReview article

Abstract

Introduction: Liver cirrhosis (20-25%), hepatocellular carcinoma (1.5-3%), insulin resistance (30-40%) and type 2 diabetes (25-30%) are common complications in patients with chronic hepatitis C virus (HCV) infection; however, data are missing from Hungary. Aim: To determine the prevalence of diabetes and insulin resistance in Hungarian HCV patients; to evaluate treatment-induced metabolic changes in relation to diabetes/insulin resistance and virological response and to perform a sustained follow-up for hepatocellular carcinoma detection. Method: We enrolled 150 Hungarian HCV genotype 1 patients (mean age: 48.55 ± 8.55 years, male/female ratio: 45/55%) from 2007-2012. We analysed their baseline, week 12, and end of therapeutic follow-up (24 weeks after interferon-based therapy completion) laboratory data. We performed a 5-year follow-up (2012-2017). Results: The prevalence of insulin sensitivity, insulin resistance and diabetes was 37.4%, 35.3% and 27.3%, respectively. Insulin resistant and diabetic patients showed a decrease in fasting glucose from baseline to end of follow-up (5.47 ± 0.66 vs. 5.08 ± 0.60, p<0.001; 7.90 ± 2.67 vs. 7.04 ± 2.75, p = 0.006), as did both the sustained responder and non-responder groups. Treatment efficacy rate was poor in diabetic vs. insulin sensitive and insulin resistant groups (17% vs. 46% and 40%); insulin sensitivity was not a predictor of virological response. Three participants with diabetes were diagnosed with hepatocellular carcinoma during follow-up by regular ultrasound examinations. Conclusion: Hungarian HCV patients showed high prevalence of diabetes and insulin resistance, though antiviral therapy caused favourable changes in their carbohydrate metabolism. Antiviral therapy was less effective in diabetic patients. Follow-up ultrasound examinations are required for hepatocellular carcinoma in HCV patients, especially those with diabetes.

Original languageHungarian
Pages (from-to)1591-1602
Number of pages12
JournalOrvosi hetilap
Volume160
Issue number40
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Hungary
Chronic Hepatitis C
Hepacivirus
Type 2 Diabetes Mellitus
Insulin Resistance
Hepatocellular Carcinoma
Insulin
Antiviral Agents
Therapeutics
Carbohydrate Metabolism
Virus Diseases
Liver Cirrhosis
Interferons
Fasting
Genotype
Glucose

ASJC Scopus subject areas

  • Medicine(all)

Cite this

2-es típusú diabetes mellitus, inzulinrezisztencia és májrák idült hepatitis C-fertozésben : Északkelet-magyarországi adatok. / Béla, Lombay; Roland, Szilágyi; Szalay, F.

In: Orvosi hetilap, Vol. 160, No. 40, 01.01.2019, p. 1591-1602.

Research output: Contribution to journalReview article

@article{1288028172184608ad9c5019b641a96b,
title = "2-es t{\'i}pus{\'u} diabetes mellitus, inzulinrezisztencia {\'e}s m{\'a}jr{\'a}k id{\"u}lt hepatitis C-fertoz{\'e}sben: {\'E}szakkelet-magyarorsz{\'a}gi adatok",
abstract = "Introduction: Liver cirrhosis (20-25{\%}), hepatocellular carcinoma (1.5-3{\%}), insulin resistance (30-40{\%}) and type 2 diabetes (25-30{\%}) are common complications in patients with chronic hepatitis C virus (HCV) infection; however, data are missing from Hungary. Aim: To determine the prevalence of diabetes and insulin resistance in Hungarian HCV patients; to evaluate treatment-induced metabolic changes in relation to diabetes/insulin resistance and virological response and to perform a sustained follow-up for hepatocellular carcinoma detection. Method: We enrolled 150 Hungarian HCV genotype 1 patients (mean age: 48.55 ± 8.55 years, male/female ratio: 45/55{\%}) from 2007-2012. We analysed their baseline, week 12, and end of therapeutic follow-up (24 weeks after interferon-based therapy completion) laboratory data. We performed a 5-year follow-up (2012-2017). Results: The prevalence of insulin sensitivity, insulin resistance and diabetes was 37.4{\%}, 35.3{\%} and 27.3{\%}, respectively. Insulin resistant and diabetic patients showed a decrease in fasting glucose from baseline to end of follow-up (5.47 ± 0.66 vs. 5.08 ± 0.60, p<0.001; 7.90 ± 2.67 vs. 7.04 ± 2.75, p = 0.006), as did both the sustained responder and non-responder groups. Treatment efficacy rate was poor in diabetic vs. insulin sensitive and insulin resistant groups (17{\%} vs. 46{\%} and 40{\%}); insulin sensitivity was not a predictor of virological response. Three participants with diabetes were diagnosed with hepatocellular carcinoma during follow-up by regular ultrasound examinations. Conclusion: Hungarian HCV patients showed high prevalence of diabetes and insulin resistance, though antiviral therapy caused favourable changes in their carbohydrate metabolism. Antiviral therapy was less effective in diabetic patients. Follow-up ultrasound examinations are required for hepatocellular carcinoma in HCV patients, especially those with diabetes.",
keywords = "Hepatitis C virus, Hepatocellular carcinoma, Insulin resistance, Type 2 diabetes mellitus",
author = "Lombay B{\'e}la and Szil{\'a}gyi Roland and F. Szalay",
year = "2019",
month = "1",
day = "1",
doi = "10.1556/650.2019.31522",
language = "Hungarian",
volume = "160",
pages = "1591--1602",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "40",

}

TY - JOUR

T1 - 2-es típusú diabetes mellitus, inzulinrezisztencia és májrák idült hepatitis C-fertozésben

T2 - Északkelet-magyarországi adatok

AU - Béla, Lombay

AU - Roland, Szilágyi

AU - Szalay, F.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Introduction: Liver cirrhosis (20-25%), hepatocellular carcinoma (1.5-3%), insulin resistance (30-40%) and type 2 diabetes (25-30%) are common complications in patients with chronic hepatitis C virus (HCV) infection; however, data are missing from Hungary. Aim: To determine the prevalence of diabetes and insulin resistance in Hungarian HCV patients; to evaluate treatment-induced metabolic changes in relation to diabetes/insulin resistance and virological response and to perform a sustained follow-up for hepatocellular carcinoma detection. Method: We enrolled 150 Hungarian HCV genotype 1 patients (mean age: 48.55 ± 8.55 years, male/female ratio: 45/55%) from 2007-2012. We analysed their baseline, week 12, and end of therapeutic follow-up (24 weeks after interferon-based therapy completion) laboratory data. We performed a 5-year follow-up (2012-2017). Results: The prevalence of insulin sensitivity, insulin resistance and diabetes was 37.4%, 35.3% and 27.3%, respectively. Insulin resistant and diabetic patients showed a decrease in fasting glucose from baseline to end of follow-up (5.47 ± 0.66 vs. 5.08 ± 0.60, p<0.001; 7.90 ± 2.67 vs. 7.04 ± 2.75, p = 0.006), as did both the sustained responder and non-responder groups. Treatment efficacy rate was poor in diabetic vs. insulin sensitive and insulin resistant groups (17% vs. 46% and 40%); insulin sensitivity was not a predictor of virological response. Three participants with diabetes were diagnosed with hepatocellular carcinoma during follow-up by regular ultrasound examinations. Conclusion: Hungarian HCV patients showed high prevalence of diabetes and insulin resistance, though antiviral therapy caused favourable changes in their carbohydrate metabolism. Antiviral therapy was less effective in diabetic patients. Follow-up ultrasound examinations are required for hepatocellular carcinoma in HCV patients, especially those with diabetes.

AB - Introduction: Liver cirrhosis (20-25%), hepatocellular carcinoma (1.5-3%), insulin resistance (30-40%) and type 2 diabetes (25-30%) are common complications in patients with chronic hepatitis C virus (HCV) infection; however, data are missing from Hungary. Aim: To determine the prevalence of diabetes and insulin resistance in Hungarian HCV patients; to evaluate treatment-induced metabolic changes in relation to diabetes/insulin resistance and virological response and to perform a sustained follow-up for hepatocellular carcinoma detection. Method: We enrolled 150 Hungarian HCV genotype 1 patients (mean age: 48.55 ± 8.55 years, male/female ratio: 45/55%) from 2007-2012. We analysed their baseline, week 12, and end of therapeutic follow-up (24 weeks after interferon-based therapy completion) laboratory data. We performed a 5-year follow-up (2012-2017). Results: The prevalence of insulin sensitivity, insulin resistance and diabetes was 37.4%, 35.3% and 27.3%, respectively. Insulin resistant and diabetic patients showed a decrease in fasting glucose from baseline to end of follow-up (5.47 ± 0.66 vs. 5.08 ± 0.60, p<0.001; 7.90 ± 2.67 vs. 7.04 ± 2.75, p = 0.006), as did both the sustained responder and non-responder groups. Treatment efficacy rate was poor in diabetic vs. insulin sensitive and insulin resistant groups (17% vs. 46% and 40%); insulin sensitivity was not a predictor of virological response. Three participants with diabetes were diagnosed with hepatocellular carcinoma during follow-up by regular ultrasound examinations. Conclusion: Hungarian HCV patients showed high prevalence of diabetes and insulin resistance, though antiviral therapy caused favourable changes in their carbohydrate metabolism. Antiviral therapy was less effective in diabetic patients. Follow-up ultrasound examinations are required for hepatocellular carcinoma in HCV patients, especially those with diabetes.

KW - Hepatitis C virus

KW - Hepatocellular carcinoma

KW - Insulin resistance

KW - Type 2 diabetes mellitus

UR - http://www.scopus.com/inward/record.url?scp=85072745725&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072745725&partnerID=8YFLogxK

U2 - 10.1556/650.2019.31522

DO - 10.1556/650.2019.31522

M3 - Review article

C2 - 31565976

AN - SCOPUS:85072745725

VL - 160

SP - 1591

EP - 1602

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 40

ER -